News CHMP Backs Cenegermin (Oxervate) for Neurotrophic Keratitis by Medscape • 2017/05/19 • 0 Comments The CHMP has recommended granting marketing authorization for Oxervate for the treatment of adults with moderate or severe neurotrophic keratitis. International Approvals Full Story →